Literature DB >> 19586907

Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors.

Micky D Tortorella1, Alfredo G Tomasselli, Karl J Mathis, Mark E Schnute, Scott S Woodard, Grace Munie, Jennifer M Williams, Nicole Caspers, Arthur J Wittwer, Anne-Marie Malfait, Huey-Sheng Shieh.   

Abstract

Several inhibitors of a series of cis-1(S)2(R)-amino-2-indanol-based compounds were reported to be selective for the aggrecanases, ADAMTS-4 and -5 over other metalloproteases. To understand the nature of this selectivity for aggrecanases, the inhibitors, along with the broad spectrum metalloprotease inhibitor marimastat, were independently bound to the catalytic domain of ADAMTS-5, and the corresponding crystal structures were determined. By comparing the structures, it was determined that the specificity of the relative inhibitors for ADAMTS-5 was not driven by a specific interaction, such as zinc chelation, hydrogen bonding, or charge interactions, but rather by subtle and indirect factors, such as water bridging, ring rigidity, pocket size, and shape, as well as protein conformation flexibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586907      PMCID: PMC2782012          DOI: 10.1074/jbc.M109.029116

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  High-throughput screening of enzyme inhibitors: simultaneous determination of tight-binding inhibition constants and enzyme concentration.

Authors:  P Kuzmic; K C Elrod; L M Cregar; S Sideris; R Rai; J W Janc
Journal:  Anal Biochem       Date:  2000-11-01       Impact factor: 3.365

2.  Potent P1' biphenylmethyl substituted aggrecanase inhibitors.

Authors:  Wenqing Yao; Michael Chao; Zelda R Wasserman; Rui Qin Liu; Maryanne B Covington; Robert Newton; David Christ; Ruth R Wexler; Carl P Decicco
Journal:  Bioorg Med Chem Lett       Date:  2002-01-07       Impact factor: 2.823

3.  Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.

Authors:  W Yao; Z R Wasserman; M Chao; G Reddy; E Shi; R Q Liu; M B Covington; E C Arner; M A Pratta; M Tortorella; R L Magolda; R Newton; M Qian; M D Ribadeneira; D Christ; R R Wexler; C P Decicco
Journal:  J Med Chem       Date:  2001-10-11       Impact factor: 7.446

4.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

Authors:  R W Farndale; D J Buttle; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1986-09-04

5.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips.

Authors:  H J Mankin; L Lippiello
Journal:  J Bone Joint Surg Am       Date:  1970-04       Impact factor: 5.284

6.  A two step purification of recombinant human interleukin-1 beta expressed in E. coli.

Authors:  A W Yem; K A Curry; C S Tomich; M R Deibel
Journal:  Immunol Invest       Date:  1988 Aug-Oct       Impact factor: 3.657

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

Review 8.  Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis.

Authors:  M D Tortorella; A M Malfait
Journal:  Curr Pharm Biotechnol       Date:  2008-02       Impact factor: 2.837

9.  A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.

Authors:  C G Knight; F Willenbrock; G Murphy
Journal:  FEBS Lett       Date:  1992-01-27       Impact factor: 4.124

10.  Aggrecan protects cartilage collagen from proteolytic cleavage.

Authors:  Michael A Pratta; Wenqing Yao; Carl Decicco; Micky D Tortorella; Riu-Qin Liu; Robert A Copeland; Ronald Magolda; Robert C Newton; James M Trzaskos; Elizabeth C Arner
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

View more
  15 in total

1.  125I-Angiotensin 1-7 binds to a different site than angiotensin 1-7 in tissue membrane preparations.

Authors:  Filipe F Stoyell-Conti; Sarin Itty; Christy Abraham; Katya Rigatto; Crystal A West; Robert C Speth
Journal:  Endocrine       Date:  2021-01-07       Impact factor: 3.633

Review 2.  Roles of microRNA and signaling pathway in osteoarthritis pathogenesis.

Authors:  Bin Xu; Yao-yao Li; Jun Ma; Fu-xing Pei
Journal:  J Zhejiang Univ Sci B       Date:  2016-03       Impact factor: 3.066

3.  Structure analysis reveals the flexibility of the ADAMTS-5 active site.

Authors:  Huey-Sheng Shieh; Alfredo G Tomasselli; Karl J Mathis; Mark E Schnute; Scott S Woodard; Nicole Caspers; Jennifer M Williams; James R Kiefer; Grace Munie; Arthur Wittwer; Anne-Marie Malfait; Micky D Tortorella
Journal:  Protein Sci       Date:  2011-04       Impact factor: 6.725

4.  The murine goblet cell protein mCLCA3 is a zinc-dependent metalloprotease with autoproteolytic activity.

Authors:  Melanie K Bothe; Lars Mundhenk; Matthias Kaup; Christoph Weise; Achim D Gruber
Journal:  Mol Cells       Date:  2011-11-09       Impact factor: 5.034

Review 5.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

6.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

Review 7.  Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug Targets.

Authors:  Rachel E Miller; Yongzhi Lu; Micky D Tortorella; Anne-Marie Malfait
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 8.  Molecular mechanisms of the cartilage-specific microRNA-140 in osteoarthritis.

Authors:  Rui Zhang; Jie Ma; Jianfeng Yao
Journal:  Inflamm Res       Date:  2013-08-14       Impact factor: 4.575

Review 9.  The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family.

Authors:  Richard Kelwick; Ines Desanlis; Grant N Wheeler; Dylan R Edwards
Journal:  Genome Biol       Date:  2015-05-30       Impact factor: 13.583

Review 10.  Proteases involved in cartilage matrix degradation in osteoarthritis.

Authors:  Linda Troeberg; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2011-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.